The gadget stays the identical, however can have a bigger cartridge that accommodates 4, 1 mg doses.
Novo Nordisk has streamlined its 1 mg semaglutide (Ozempic) injection for kind 2 diabetes, decreasing the necessity for two pens to 1 every month, based on a press launch.
The gadget stays the identical, however can have a bigger cartridge that accommodates 4, 1 mg doses. As well as, the brand new packaging will present 1 pen and 4 needles to accommodate the 4 injections per 28 days (1 injection per week). The gadget isn’t a single-use pen and shouldn’t be thrown out till 4 doses are administered.
The one month-to-month pen will turn into accessible beginning in April, and sufferers might must obtain a brand new prescription from their well being care supplier in an effort to obtain the brand new packaging. Additional, sufferers ought to proceed to take their medicine as prescribed by their well being care supplier, based on the press launch.
Novo Nordisk transitions to single pen for month-to-month provide of Ozempic® (semaglutide) injection 1 mg [email]. Revealed April 1, 2021. Accessed April 5, 2021.